NewsRoom Articles - Page 1264 of 1352

ThursdayFeb 16, 2017 1:15 pm

KaloBios Pharmaceuticals (KBIO) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

KaloBios Pharmaceuticals (OTC: KBIO) develops monoclonal antibody therapeutics for the treatment of cancer in the United States. Its lead product candidate is benznidazole for the treatment of Chagas disease. The company is also developing proprietary monoclonal antibodies, including lenzilumab, which is in phase I clinical trial in patients with chronic myelomonocytic leukemia; and ifabotuzumab that has completed phase I/II clinical trial in multiple hematologic malignancies, as well as evaluating further studies of ifabotuzumab in rare solid tumors, such as glioblastoma, other brain cancers in children, and rare hematologic cancer indications. For more information, visit the company's website at www.kalobios.com. About…

ThursdayFeb 16, 2017 12:45 pm

RXi Pharmaceuticals (NASDAQ: RXII) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

RXi Pharmaceuticals (NASDAQ: RXII) is a clinical-stage RNAi company that focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. Its clinical development programs include RXI-109, a self-delivering RNAi compound in phase IIa clinical trial for prevention or reduction of dermal scarring following surgery or trauma, as well as for the management of hypertrophic scars and keloids, and in a phase I/II clinical trial in retinal scarring. RXi is also developing RXI-109 for the treatment of an ophthalmic indication, focusing on retinal and corneal scarring; and Samcyprone, in phase II clinical trial for the treatment of…

ThursdayFeb 16, 2017 12:41 pm

ORhub, Inc. (ORHB) Aims to Cut Annual US Health Care Spending by $250 Billion

ORhub, Inc. (OTC: ORHB), is a cloud-based health care software-as-a-service company whose primary aim is to improve the outcome and reduce costs of surgical care in a variety of hospitals and health care institutions in the United States. Because many hospitals still rely on paper documentation to track everything that occurs during an operation, there is more space for mistakes, missing information, delays, and payment problems, as well as, generally, less opportunity to effectively improve procedures. ORhub’s digital platform eliminates a variety of the limitations and problems inherent with paper documentation. Aside from reducing potential mistakes, the platform creates automatic…

ThursdayFeb 16, 2017 11:45 am

AudioEye, Inc. (AEYE) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

AudioEye (OTC: AEYE) provides web accessibility solutions to Internet, print, broadcast and other media to people in the United States. The company’s solutions are designed to build accessibility into existing website or web applications; quickly conform to ADA-related standards and best practices; outsource burden of accessibility in time and money-saving manners; and to bridge the gap until accessibility issues can be fixed at the source. The AudioEye Digital Accessibility Platform is designed to be the developer’s comprehensive web accessibility tool. This tool empowers auditors, designers, and developers to understand issues of accessibility and improve website infrastructure through the use of…

ThursdayFeb 16, 2017 11:45 am

Rexahn Pharmaceuticals, Inc. (NYSE: RNN) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Rexahn Pharmaceuticals (NYSE: RNN) is a clinical stage biopharmaceutical company that discovers, develops, and commercializes treatments for cancer. The company’s clinical stage oncology candidates include Archexin that completed a pilot phase II a clinical trial for the treatment of pancreatic cancer; RX-3117, which is in phase I b clinical trial for the treatment of patients with solid tumors; and Supinoxin that is in phase I clinical trial for patients with solid tumors. It is also involved in developing RX-21101, an N-(2-Hydroxypropyl) methacrylamide-docetaxel-folate, which is in pre-clinical development stage used for the treatment of tumors. For more information visit the company’s…

ThursdayFeb 16, 2017 11:15 am

Acme United Corp. (NYSE: ACU) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Acme United (NYSE: ACU) an innovative supplier of cutting devices and safety products for school, home, office, hardware and industrial use. Its leading brands include Westcott®,a major brand for scissors and rulers; Clauss®, which primarily manufactures cutting instruments for professionals in the hardware & industrial, lawn & garden, food processing, sewing and housewares markets; Camillus®, a recognizable brand in the knife industry; fishing gear brand CUDA®; DMT, a manufacturer of large diamond grinding and polishing wheels for industrial application; as well as First Aid Only®, PhysiciansCare® and Pac-Kit®. The company has operations in the United States, Canada, Europe (located in…

ThursdayFeb 16, 2017 11:15 am

Cancer Genetics, Inc. (NASDAQ: CGIX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Cancer Genetics (NASDAQ: CGIX) develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. The company’s tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biopharmaceutical companies involved in oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. Its clinical services provide information on diagnosis, prognosis, and predicting treatment outcomes of cancers to guide patient management. For more information, visit the company’s website at…

ThursdayFeb 16, 2017 10:45 am

Arch Therapeutics (ARTH) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Arch Therapeutics (OTCQB: ARTH) is a biotech company developing an innovative, elegant and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field we call, "stasis and barrier applications." For more information, visit the company's website at www.archtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial…

ThursdayFeb 16, 2017 10:45 am

Live Ventures, Inc. (NASDAQ: LIVE) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Live Ventures (NASDAQ: LIVE) is a diversified growth holding company with a strategic focus on acquiring United States-based middle market growth manufacturing and value-add distribution companies. The company operates several wholly owned subsidiaries and has a strategic focus on acquiring profitable companies that have demonstrated a strong history of earnings power. Live Ventures provides, among other businesses, marketing solutions that boost customer awareness and merchant visibility on the Internet. For more information, visit the company’s website at www.live-ventures.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…

ThursdayFeb 16, 2017 10:21 am

Net Element (NASDAQ: NETE) Issues Purchase Notices to Esousa Holdings, LLC Aggregating $1.35 Million for 1,578,877 Shares

Net Element (NASDAQ: NETE), in a series of three 8K SEC filings from January 19, 2017, through February 8, 2017 (www.netelement.com/en/ir), has presented to Esousa Holdings, LLC purchase notices aggregating $1.35 million for 1,578,877 shares of its common stock at a price per share ranging from $0.83 to $0.861. Net Element is a technology provider with a platform that integrates mobile and transactional services. Aptito is its point-of-sale brand, which is cloud-based. Its TOT Group subsidiary also handles transaction processing in the U.S. through Unified Payments. TOT Money is its Russia-based mobile payments provider. Net Element serves the restaurant, retail…

Financial news and publishing for public and private companies

Contact us: 512.354.7000